Jakubowiak, A. J., Wróbel, T., Jamroziak, K., Kubicki, T., Robak, P., Czyz, J., Tyczyńska, A., Druzd-Sitek, A., Giannopoulos, K., Łojko-Dankowska, A., Matuszak, M., Gil, L., Puła, B., Rybka, J., Usnarska-Zubkiewicz, L., Czabak, O., Pula, A. E., Derman, B. A., Karrison, T., Dytfeld, D. (2025). Carfilzomib, lenalidomide, and dexamethasone (KRd) as maintenance therapy after autologous stem-cell transplantation (ASCT) in patients with newly diagnosed multiple myeloma (NDMM).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7535